Fulgent Net Receivables vs Non Currrent Assets Other Analysis

FLGT Stock  USD 20.24  0.11  0.55%   
Fulgent Genetics financial indicator trend analysis is much more than just examining Fulgent Genetics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fulgent Genetics is a good investment. Please check the relationship between Fulgent Genetics Net Receivables and its Non Currrent Assets Other accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

Net Receivables vs Non Currrent Assets Other

Net Receivables vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fulgent Genetics Net Receivables account and Non Currrent Assets Other. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Fulgent Genetics' Net Receivables and Non Currrent Assets Other is -0.03. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Fulgent Genetics, assuming nothing else is changed. The correlation between historical values of Fulgent Genetics' Net Receivables and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Fulgent Genetics are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Net Receivables i.e., Fulgent Genetics' Net Receivables and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

-0.03
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Receivables

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Fulgent Genetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fulgent Genetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulgent Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.At this time, Fulgent Genetics' Discontinued Operations is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 93.4 M in 2024, whereas Tax Provision is likely to drop slightly above 2.5 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit777.1M366.9M104.5M180.0M
Total Revenue992.6M619.0M289.2M266.7M

Fulgent Genetics fundamental ratios Correlations

0.920.861.00.990.97-0.910.980.850.870.87-0.180.430.90.640.930.670.840.920.880.970.90.96-0.59-0.590.8
0.920.940.90.920.88-0.910.840.940.890.73-0.150.40.840.870.880.880.660.920.950.840.880.85-0.6-0.60.63
0.860.940.840.830.76-0.870.781.00.910.55-0.310.480.920.90.880.90.610.930.990.720.950.72-0.56-0.560.47
1.00.90.840.990.98-0.90.990.840.860.88-0.180.430.890.620.930.640.850.910.870.970.890.96-0.59-0.590.81
0.990.920.830.990.97-0.930.970.820.880.88-0.060.470.870.650.920.680.790.90.860.960.870.96-0.6-0.60.79
0.970.880.760.980.97-0.830.960.770.770.96-0.160.270.780.540.870.570.870.860.811.00.781.0-0.59-0.590.9
-0.91-0.91-0.87-0.9-0.93-0.83-0.85-0.85-0.98-0.66-0.13-0.72-0.9-0.81-0.89-0.83-0.53-0.9-0.88-0.79-0.92-0.790.580.58-0.51
0.980.840.780.990.970.96-0.850.770.820.88-0.20.420.880.520.880.550.880.850.810.960.860.95-0.48-0.480.83
0.850.941.00.840.820.77-0.850.770.890.56-0.340.430.90.890.890.90.630.940.990.730.930.73-0.6-0.60.49
0.870.890.910.860.880.77-0.980.820.890.570.050.740.940.830.910.850.510.930.920.740.960.72-0.57-0.570.43
0.870.730.550.880.880.96-0.660.880.560.57-0.140.060.580.310.730.340.870.690.620.970.570.97-0.47-0.470.98
-0.18-0.15-0.31-0.18-0.06-0.16-0.13-0.2-0.340.05-0.140.46-0.23-0.03-0.21-0.01-0.55-0.22-0.28-0.2-0.2-0.20.140.14-0.31
0.430.40.480.430.470.27-0.720.420.430.740.060.460.660.530.490.54-0.010.470.450.240.660.21-0.24-0.24-0.11
0.90.840.920.890.870.78-0.90.880.90.940.58-0.230.660.720.920.740.680.920.910.770.990.74-0.56-0.560.5
0.640.870.90.620.650.54-0.810.520.890.830.31-0.030.530.720.681.00.250.770.870.480.790.49-0.49-0.490.17
0.930.880.880.930.920.87-0.890.880.890.910.73-0.210.490.920.680.70.740.990.910.860.930.85-0.78-0.780.65
0.670.880.90.640.680.57-0.830.550.90.850.34-0.010.540.741.00.70.270.790.890.50.80.52-0.48-0.480.2
0.840.660.610.850.790.87-0.530.880.630.510.87-0.55-0.010.680.250.740.270.70.650.90.640.9-0.45-0.450.93
0.920.920.930.910.90.86-0.90.850.940.930.69-0.220.470.920.770.990.790.70.960.830.930.83-0.74-0.740.61
0.880.950.990.870.860.81-0.880.810.990.920.62-0.280.450.910.870.910.890.650.960.770.940.77-0.57-0.570.54
0.970.840.720.970.961.0-0.790.960.730.740.97-0.20.240.770.480.860.50.90.830.770.761.0-0.56-0.560.93
0.90.880.950.890.870.78-0.920.860.930.960.57-0.20.660.990.790.930.80.640.930.940.760.74-0.57-0.570.48
0.960.850.720.960.961.0-0.790.950.730.720.97-0.20.210.740.490.850.520.90.830.771.00.74-0.57-0.570.93
-0.59-0.6-0.56-0.59-0.6-0.590.58-0.48-0.6-0.57-0.470.14-0.24-0.56-0.49-0.78-0.48-0.45-0.74-0.57-0.56-0.57-0.571.0-0.41
-0.59-0.6-0.56-0.59-0.6-0.590.58-0.48-0.6-0.57-0.470.14-0.24-0.56-0.49-0.78-0.48-0.45-0.74-0.57-0.56-0.57-0.571.0-0.41
0.80.630.470.810.790.9-0.510.830.490.430.98-0.31-0.110.50.170.650.20.930.610.540.930.480.93-0.41-0.41
Click cells to compare fundamentals

Fulgent Genetics Account Relationship Matchups

Fulgent Genetics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets88.8M700.5M1.3B1.4B1.2B1.3B
Other Current Liab3.6M35.0M28.4M24.2M26.9M28.3M
Total Current Liabilities6.0M131.1M112.8M116.2M73.0M49.4M
Total Stockholder Equity82.8M569.4M1.2B1.3B1.1B1.2B
Net Tangible Assets82.8M569.4M1.2B973.0M1.1B1.2B
Property Plant And Equipment Net6.0M40.2M62.3M81.4M95.6M100.4M
Net Debt(9.3M)(71.6M)(143.6M)(58.9M)(82.2M)(78.1M)
Retained Earnings(63.4M)150.9M657.6M801M633.2M664.8M
Accounts Payable1.6M26.5M20.5M23.1M15.4M10.3M
Cash12.0M87.4M164.9M79.5M97.5M50.9M
Non Current Assets Total12.0M84.7M204.3M480.4M727.5M763.9M
Non Currrent Assets Other(36.8M)(88.0M)142.0M(287.4M)22.7M23.9M
Other Assets251K44.5M912.6M26.6M1.00.95
Cash And Short Term Investments70.2M431.9M935.5M852.9M424.2M312.5M
Net Receivables6.6M204.1M143.3M52.7M57.4M52.9M
Common Stock Shares Outstanding18.7M24.1M31.0M31.0M29.8M23.5M
Liabilities And Stockholders Equity88.8M700.5M1.3B1.4B1.2B1.3B
Inventory277K16.5M12.2M4.3M5.8M4.4M
Other Current Assets277K3.7M6.0M44.5M26.2M27.6M
Other Stockholder Equity146.1M418.1M501.9M486.6M501.7M263.1M
Total Liab6.0M131.1M112.8M116.2M102.0M52.6M
Property Plant And Equipment Gross8.6M41.0M81.9M124.6M135.1M141.9M
Total Current Assets76.8M615.7M1.1B905.6M507.8M365.6M
Accumulated Other Comprehensive Income146K438K(759K)(20.9M)1.2M1.3M
Property Plant Equipment8.6M40.2M62.3M98.9M113.8M119.4M
Retained Earnings Total Equity(63.0M)(63.4M)150.9M657.6M756.2M794.0M
Short Term Investments58.3M344.4M770.7M773.4M326.7M326.9M
Non Current Liabilities Total2.3M959K7.5M28.1M29.0M30.5M
Capital Surpluse114.2M146.1M418.1M501.9M577.2M606.1M
Long Term Investments42.8M132.5M507.0M339.0M444.0M466.2M
Non Current Liabilities Other2.3M959K7.5M28.1M11.0M6.8M
Net Invested Capital82.8M584.4M1.2B1.3B1.1B688.3M
Net Working Capital33.4M393.5M961.6M539.8M434.8M381.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Fulgent Stock Analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.